95 related articles for article (PubMed ID: 15266011)
1. Ligand-binding residues integrate affinity and efficacy in the NMDA receptor.
Kalbaugh TL; VanDongen HM; VanDongen AM
Mol Pharmacol; 2004 Aug; 66(2):209-19. PubMed ID: 15266011
[TBL] [Abstract][Full Text] [Related]
2. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
3. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
4. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
Hansen KB; Clausen RP; Bjerrum EJ; Bechmann C; Greenwood JR; Christensen C; Kristensen JL; Egebjerg J; Bräuner-Osborne H
Mol Pharmacol; 2005 Dec; 68(6):1510-23. PubMed ID: 16131614
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
Laube B; Schemm R; Betz H
Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
Inanobe A; Furukawa H; Gouaux E
Neuron; 2005 Jul; 47(1):71-84. PubMed ID: 15996549
[TBL] [Abstract][Full Text] [Related]
7. Subunit arrangement and function in NMDA receptors.
Furukawa H; Singh SK; Mancusso R; Gouaux E
Nature; 2005 Nov; 438(7065):185-92. PubMed ID: 16281028
[TBL] [Abstract][Full Text] [Related]
8. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
Hatton CJ; Paoletti P
Neuron; 2005 Apr; 46(2):261-74. PubMed ID: 15848804
[TBL] [Abstract][Full Text] [Related]
9. The NR1 M3 domain mediates allosteric coupling in the N-methyl-D-aspartate receptor.
Blanke ML; VanDongen AM
Mol Pharmacol; 2008 Aug; 74(2):454-65. PubMed ID: 18483226
[TBL] [Abstract][Full Text] [Related]
10. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
[TBL] [Abstract][Full Text] [Related]
11. Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors.
Awobuluyi M; Yang J; Ye Y; Chatterton JE; Godzik A; Lipton SA; Zhang D
Mol Pharmacol; 2007 Jan; 71(1):112-22. PubMed ID: 17047094
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
[TBL] [Abstract][Full Text] [Related]
13. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket.
Malherbe P; Mutel V; Broger C; Perin-Dureau F; Kemp JA; Neyton J; Paoletti P; Kew JN
J Pharmacol Exp Ther; 2003 Dec; 307(3):897-905. PubMed ID: 14534359
[TBL] [Abstract][Full Text] [Related]
14. Development of a three-dimensional model for the N-methyl-D-aspartate NR2A subunit.
Grazioso G; Moretti L; Scapozza L; De Amici M; De Micheli C
J Med Chem; 2005 Aug; 48(17):5489-94. PubMed ID: 16107147
[TBL] [Abstract][Full Text] [Related]
15. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
16. In silico mutation of cysteine residues in the ligand-binding domain of an N-methyl-D-aspartate receptor.
Kaye SL; Sansom MS; Biggin PC
Biochemistry; 2007 Feb; 46(8):2136-45. PubMed ID: 17269660
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the human NMDA receptor subunit NR3A glycine binding site.
Nilsson A; Duan J; Mo-Boquist LL; Benedikz E; Sundström E
Neuropharmacology; 2007 Mar; 52(4):1151-9. PubMed ID: 17320117
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating.
Low CM; Lyuboslavsky P; French A; Le P; Wyatte K; Thiel WH; Marchan EM; Igarashi K; Kashiwagi K; Gernert K; Williams K; Traynelis SF; Zheng F
Mol Pharmacol; 2003 Jun; 63(6):1212-22. PubMed ID: 12761330
[TBL] [Abstract][Full Text] [Related]
19. The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
Clausen RP; Hansen KB; Calí P; Nielsen B; Greenwood JR; Begtrup M; Egebjerg J; Bräuner-Osborne H
Eur J Pharmacol; 2004 Sep; 499(1-2):35-44. PubMed ID: 15363949
[TBL] [Abstract][Full Text] [Related]
20. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
